RAAS activation is associated with visceral adiposity and insulin resistance among HIV-infected patients

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 8, 2015, Pages 2873-2882

  Srinivasa, Suman ^a   Fitch, Kathleen V ^a   Wong, Kimberly ^a   Torriani, Martin ^a   Mayhew, Caitlin ^a   Stanley, Takara ^a   Lo, Janet ^a   Adler, Gail K ^a   Grinspoon, Steven K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; ANTIRETROVIRUS AGENT; CORTICOTROPIN;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INSULIN RESISTANCE; INTRAABDOMINAL FAT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PATHOPHYSIOLOGY; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; SODIUM RESTRICTION; ABDOMINAL OBESITY; ADOLESCENT; CLINICAL TRIAL; COMPLICATION; CONTROLLED CLINICAL TRIAL; DRUG EFFECTS; HUMAN IMMUNODEFICIENCY VIRUS 1; INFLAMMATION; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADIPOSITY; ADOLESCENT; ADULT; AGED; ALDOSTERONE; ANGIOTENSIN II; DIET, SODIUM-RESTRICTED; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY, ABDOMINAL; RENIN-ANGIOTENSIN SYSTEM; YOUNG ADULT;

EID: 84939195325     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-1461     Document Type: Article

References (38)

1. Guo C, Ricchiuti V, Lian BQ, et al. Mineralocorticoid receptor blockade reverses obesity-related changes in expression of adiponectin, peroxisome proliferator-activated receptor-γ, and proinflammatory adipokines. Circulation. 2008;117:2253-2261.
2. Bentley-Lewis R, Adler GK, Perlstein T, et al. Body mass index predicts aldosterone production in normotensive adults on a high-salt diet. J Clin Endocrinol Metab. 2007;92:4472-4475.
3. Garg R, Hurwitz S, Williams GH, Hopkins PN, Adler GK. Aldosterone production and insulin resistance in healthy adults. J Clin Endocrinol Metab. 2010;95:1986-1990.
4. Lo J, Looby SE, Wei J, Adler GK, Grinspoon SK. Increased aldosterone among HIV-infected women with visceral fat accumulation. AIDS. 2009;23:2366-2370.
5. Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat is an independent predictor of all-cause mortality in men. Obesity (Silver Spring). 2006;14:336-341.
6. Rondinone CM, Rodbard D, Baker ME. Aldosterone stimulated differentiation of mouse 3T3-L1 cells into adipocytes. Endocrinology. 1993;132:2421-2426.
7. Saye JA, Cassis LA, Sturgill TW, Lynch KR, Peach MJ. Angiotensinogen gene expression in 3T3-L1 cells. Am J Physiol. 1989; 256:C448-C451.
8. Karlsson C, Lindell K, Ottosson M, Sjostrom L, Carlsson B, Carlsson LM. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab. 1998;83:3925-3929.
9. Briones AM, Nguyen Dinh Cat A, Callera GE, et al. Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension. 2012;59:1069-1078.
10. Cassis LA, Police SB, Yiannikouris F, Thatcher SE. Local adipose tissue renin-angiotensin system. Curr Hypertens Rep. 2008;10:93-98.
11. Hadigan C, Meigs JB, Corcoran C, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis. 2001;32:130-139.
12. Joy T, Keogh HM, Hadigan C, et al. Relation of body composition to body mass index in HIV-infected patients with metabolic abnormalities. J Acquir Immune Defic Syndr. 2008;47:174-184.
13. Grunfeld C, Rimland D, Gibert CL, et al. Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study. J Acquir Immune Defic Syndr. 2007;46:283-290.
14. He Q, Engelson ES, Ionescu G, Glesby MJ, Albu JB, Kotler DP. Insulin resistance, hepatic lipid and adipose tissue distribution in HIV-infected men. Antivir Ther. 2008;13:423-428.
15. Wohl D, Scherzer R, Heymsfield S, et al. The associations of regional adipose tissue with lipid and lipoprotein levels in HIV-infected men. J Acquir Immune Defic Syndr. 2008;48:44-52.
16. Guaraldi G, Stentarelli C, Zona S, et al. Lipodystrophy and antiretroviral therapy as predictors of sub-clinical atherosclerosis in human immunodeficiency virus infected subjects. Atherosclerosis. 2010;208:222-227.
17. Troseid M, Ditlevsen S, Hvid T, et al. Reduced trunk fat and triglycerides after strength training are associated with reduced LPS levels in HIV-infected individuals. J Acquir Immune Defic Syndr. 2014;66:e52-e54.
18. Goodfriend TL, Kelley DE, Goodpaster BH, Winters SJ. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. Obes Res. 1999;7:355-362.
19. Fallo F, Della Mea P, Sonino N, et al. Adiponectin and insulin sensitivity in primary aldosteronism. Am J Hypertens. 2007;20:855-861.
20. Fallo F, Dalla Pozza A, Tecchio M, et al. Nonalcoholic fatty liver disease in primary aldosteronism: a pilot study. Am J Hypertens. 2010;23:2-5.
21. Hoffstedt J, Poirier O, Thorne A, et al. Polymorphism of the human β3-adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes. 1999;48:203-205.
22. Lonnqvist F, Thome A, Nilsell K, Hoffstedt J, Arner P. A pathogenic role of visceral fat β3-adrenoceptors in obesity. J Clin Invest. 1995; 95:1109-1116.
23. Mauriege P, Galitzky J, Berlan M, Lafontan M. Heterogeneous distribution of β and α-2 adrenoceptor binding sites in human fat cells from various fat deposits: functional consequences. Eur J Clin Invest. 1987;17:156-165.
24. Khoury N, McGill JB. Reduction in insulin sensitivity following administration of the clinically used low-dose pressor, norepinephrine. Diabetes Metab Res Rev. 2011;27:604-608.
25. Sarigianni M, Bekiari E, Tsapas A, et al. Effect of epinephrine and insulin resistance on human monocytes obtained from lean and obese healthy participants: a pilot study. Angiology. 2011;62: 38-45.
26. Sigmund CD, Jones CA, Kane CM, Wu C, Lang JA, Gross KW. Regulated tissue- and cell-specific expression of the human renin gene in transgenic mice. Circ Res. 1992;70:1070-1079.
27. Hirata A, Maeda N, Hiuge A, et al. Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice. Cardiovasc Res. 2009;84:164-172.
28. Hitomi H, Kiyomoto H, Nishiyama A, et al. Aldosterone suppresses insulin signaling via the downregulation of insulin receptor substrate-1 in vascular smooth muscle cells. Hypertension. 2007;50: 750-755.
29. Wada T, Ohshima S, Fujisawa E, Koya D, Tsuneki H, Sasaoka T. Aldosterone inhibits insulin-induced glucose uptake by degradation of insulin receptor substrate (IRS) 1 and IRS2 via a reactive oxygen species-mediated pathway in 3T3-L1 adipocytes. Endocrinology. 2009;150:1662-1669.
30. Folli F, Saad MJ, Velloso L, et al. Cross talk between insulin and angiotensin II signalling systems. Exp Clin Endocrinol Diabetes. 1999;107:133-139.
31. Selvaraj J, Muthusamy T, Srinivasan C, Balasubramanian K. Impact of excess aldosterone on glucose homeostasis in adult male rat. Clin Chim Acta. 2009;407:51-57.
32. Kalupahana NS, Massiera F, Quignard-Boulange A, et al. Overproduction of angiotensinogen from adipose tissue induces adipose inflammation, glucose intolerance, and insulin resistance. Obesity (Silver Spring). 2012;20:48-56.
33. Dolan SE, Frontera W, Librizzi J, et al. Effects of a supervised homebased aerobic and progressive resistance training regimen in women infected with human immunodeficiency virus: a randomized trial. Arch Intern Med. 2006;166:1225-1231.
34. Falutz J, Allas S, Blot K, et al. Metabolic effects of a growth hormone-releasing factor in patients with HIV. N Engl J Med. 2007; 357:2359-2370.
35. Lake JE, Tseng CH, Currier JS. A pilot study of telmisartan for visceral adiposity in HIV infection: the Metabolic Abnormalities, Telmisartan, and HIV Infection (MATH) trial. PLoS One. 2013;8: e58135.
36. Alderman MH, Cohen H, Madhavan S. Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES I). Lancet. 1998;351:781-785.
37. Cohen HW, Hailpern SM, Fang J, Alderman MH. Sodium intake and mortality in the NHANES II follow-up study. Am J Med. 2006; 119:275 e277-e214.
38. DiNicolantonio JJ, Niazi AK, Sadaf R, JH OK, Lucan SC, Lavie CJ. Dietary sodium restriction: take it with a grain of salt. Am J Med. 2013;126:951-955.